Summary & Overview
HCPCS J2460: Injection, Oxytetracycline HCl, Up to 50 mg
HCPCS Level II code J2460 denotes an injection of oxytetracycline hydrochloride up to 50 mg, an injectable antibiotic used in clinical settings requiring parenteral therapy. This code matters nationally because it standardizes reporting and reimbursement for a specific dose of oxytetracycline used across outpatient clinics, physician offices, emergency departments, and hospital outpatient departments. Clear coding supports appropriate billing, inventory tracking, and clinical documentation for antimicrobial therapy.
Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical context and service settings, guidance on common billing and administrative considerations, and indications of where additional data may be needed. The publication outlines typical use cases for parenteral oxytetracycline, how the code fits into service lines involving injectable anti-infectives, and what benchmarks and payer coverage categories are commonly examined in national analyses.
This summary is intended to inform billing staff, revenue cycle professionals, and clinical administrators about the role of J2460 in claims submission and operational workflows. Data not available in the input includes specific payer reimbursement rates, associated ICD-10 diagnoses, taxonomies, and related codes.
Billing Code Overview
HCPCS Level II code J2460 represents an injection of oxytetracycline hydrochloride, up to 50 mg. This code describes a single-dose parenteral administration of the antibiotic oxytetracycline delivered by injection.
Service type: Injectable medication administration
Typical site of service: Outpatient clinic, physician office, emergency department, or hospital outpatient setting, where parenteral antibiotics are administered.
Clinical & Coding Specifications
Clinical Context
A 58-year-old male with a history of chronic prostatitis presents to an outpatient infusion clinic with signs of bacterial infection not responsive to oral tetracyclines. The treating physician orders an intramuscular injection of oxytetracycline hydrochloride for parenteral antibiotic therapy. The patient is screened for allergies, informed consent is obtained, and baseline vital signs are recorded. A licensed nurse prepares a single-dose vial of oxytetracycline up to 50 mg, performs an intramuscular administration (typically deltoid or gluteal site), monitors the patient for immediate adverse reactions for 15–30 minutes, documents lot number and dose in the medical record, and updates medication administration and billing information. Typical sites of service include outpatient infusion centers, ambulatory surgical centers when given perioperatively, emergency departments for acute infections when intramuscular therapy is indicated, and physician offices for parenteral antibiotic administration.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Standard primary payer code (no modifier) | Use when no special billing modifier applies and service is billed normally. |
22 | Increased procedural services |